Results
|
861.
|
|
|
862.
|
|
|
863.
|
|
|
864.
|
|
|
865.
|
|
|
866.
|
|
|
867.
|
|
|
868.
|
|
|
869.
|
|
|
870.
|
|
|
871.
|
|
|
872.
|
|
|
873.
|
|
|
874.
|
|
|
875.
|
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. [electronic resource] by
- Wong, Nan Soon
- Buckman, Robert A
- Clemons, Mark
- Verma, Shailendra
- Dent, Susan
- Trudeau, Maureen E
- Roche, Kathie
- Ebos, John
- Kerbel, Robert
- Deboer, Gerrit E
- Sutherland, Donald J A
- Emmenegger, Urban
- Slingerland, Joyce
- Gardner, Sandra
- Pritchard, Kathleen I
Producer: 20100304
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
876.
|
|
|
877.
|
|
|
878.
|
|
|
879.
|
|
|
880.
|
|